Recovery Act - Comparative Effectiveness Research - Ahrq

 

To improve health outcomes by providing evidence to enhance medical decisions made by patients and their medical providers. This goal is pursued by generating research comparing different interventions and strategies to prevent, diagnose, treat and monitor health conditions. Funds are available under the American Recovery and Reinvestment Act of 2009 to support research and evaluations, demonstration projects, research networks and multidisciplinary centers, predoctoral and postdoctoral training opportunities, individual fellowships, and to disseminate rigorous evaluations of the impact of different options that are available for treating a given medical condition for a particular set of patients.

Deleted 02/05/2016 (Archived.) 93.715 Agency: Department of Health and Human Services
Office: Agency for Healthcare Research and Quality Project Grants Fiscal Year 2013: No new grants were awarded by AHRQ under the Recovery Act. Fiscal Year 2014: No new grants will be awarded by AHRQ under the Recovery Act. Fiscal Year 2015: No new grants will be awarded by AHRQ under the Recovery Act. American Recovery and Reinvestment Act of 2009, Title 8, Public Law 111-5; Medicare Prescription Drug, Improvement, and Moderization Act of 2003, Title IX, Section 1013, Public Law 108-173, 42 U.S.C 1305; Social Security Act, Title XI, Part A, Public Law 74-271, 42 U.S.C 1301-1320; Public Health Service Act , Title IX, 42 U.S.C 299 et seq. Award recipients include a combination of academic institutions, States, community-based organizations, and private or non-profit national organizations. Funds will be spent to research and provide information on the relative strengths and weaknesses of various medical interventions. Such research will give clinicians and patients valid information with which to make decisions that will improve the performance of the U.S. health care system. Nonprofit organizations must submit proof of their nonprofit status when applying for grants. Costs will be determined in accordance with HHS Regulations 45 CFR 74 or 45 CFR 92 as appropriate. OMB Circular No. A-87 applies to this program. Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372. OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. No new grants will be awarded by AHRQ under the Recovery Act in FY2013 or FY2014, therefore applications are no longer being accepted. Following review for scientific merit by a group composed primarily of nonfederal scientists, grant applications may be reviewed by the National Advisory Council for Healthcare Research and Quality, after which AHRQ makes final decisions to support recommended applications. When such decisions are made, applicants are notified directly by AHRQ staff and all required steps are taken to issue the Notice of Award. Contact the headquarters or regional office, as appropriate, for application deadlines. > 180 Days. Not Applicable. Not Applicable. The proposals must first be reviewed by review groups and recommended for funding on the basis of scientific and technical merit. This includes consideration of the qualifications of the principal investigator and staff to conduct the research using appropriate methodology and budget. Applications may be reviewed for program relevance by the National Advisory Council for Healthcare Research and Quality. Those recommended proposals which are most relevant to comparative effectiveness and promote the goals of the ARRA will be funded to the extent that funds are available. The research will contribute to the health services and clinical knowledge base in comparative effectiveness of different treatment and practices from which empirically based information can be derived by patients, providers, policymakers, and other stakeholders, both immediately and over the coming decades. Grant funds will be available in FYs 2009 and 2010 for costs necessary to carry out an approved project. Unallowable costs, as well as those for which prior written approval is required, are indicated in the HHS Grants Policy Statement. Grantees must comply with all Recovery Act reporting requirements. Approximately 66% of the $300,000,000 in Recovery Act funds provided to AHRQ for CER research was awarded for discretionary grants. Grantees must submit quarterly reports in compliance with the American Recovery and Reinvestment Act of 2009. Inventions are to be reported immediately. A final progress report must be submitted within 90 days after the end of the project. Grantees must submit quarterly SF425 reports to HHS' Program Support Center (PSC). Progress reports are required to be submitted to AHRQ on an annual basis and will be based on the PHS 2590 Non-Competing Continuation Progress Report. A Federal Financial Report (FFR; SF425) must be submitted within 90 days after the end of the calendar quarter of each 12 month increment of time. A final FFR must be submitted within 90 days after the project period end date. Quarterly performance monitoring in accordance with the requirements of the Recovery Act. In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials. Records must be retained for at least three years; records shall be retained beyond the three year period if audit findings have not been resolved. This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements. Grants were approved for project periods up to 4 years. Funds were awarded for the total project in fiscal year 2009 or 2010. Costs budgeted beyond the initial 12 months of funding were restricted pending satisfactory progress. After awards were issued, funds were released in accordance with the payment procedure established by the grantee institution with DHHS, which may be an Electronic Transfer System or a Monthly Cash Request System. Method of awarding/releasing assistance: lump sum. None. Yen-Pin Chiang 540 Gaither Rd, Rockville, Maryland 20850 Email: Yen-Pin.Chiang@ahrq.hhs.gov Phone: 301-427-1493 http://effectivehealthcare.ahrq.gov 75-0910-1-7-010. (Project Grants (Discretionary)) FY 13 $0; FY 14 est $0; and FY 15 est $0 - The $310,969,115 in Recovery Act funds awarded by AHRQ in FY2010 represent AHRQ ARRA grants ($199,463,507) and AHRQ OS ARRA grants ($111,505,608). No new grants will be awarded by AHRQ in FY2014 of FY2015 under the Recovery Act. AHRQ ARRA grants: $563,672 to $9,898,332; $3,693,769 average. AHRQ OS ARRA grants: $361,109 to $11,881,843; $2,027,375 average. These are total cost figures. American Recovery and Reinvestment Act of 2009; 42 CFR 67, Regulations for Health Services Research, Evaluation, Demonstration, and Dissemination Projects as amended by Public Law 106-129; HHS Grants Policy Statement.
Not Applicable.